title: [Pathophysiological role of aldosterone in acute renal failure].
authors.affiliation: Unidad de Fisiología Molecular, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México e Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan. nab@biomedicas.unam.mx
authors.forename: Norma A
authors.initials: NA
authors.lastname: Bobadilla
mesh_terms: D043209:11-beta-Hydroxysteroid Dehydrogenase Type 2 / Q000378:metabolism; D058186:Acute Kidney Injury / Q000209:etiology / Q000503:physiopathology* / Q000517:prevention & control; D000450:Aldosterone / Q000502:physiology*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D018450:Disease Progression; D000077545:Eplerenone; D005355:Fibrosis; D006801:Humans; D007511:Ischemia / Q000150:complications / Q000503:physiopathology; D007668:Kidney / Q000098:blood supply / Q000473:pathology; D000451:Mineralocorticoid Receptor Antagonists; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy; D051381:Rats; D011918:Rats, Inbred SHR; D015427:Reperfusion Injury / Q000503:physiopathology; D013148:Spironolactone / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000450:Aldosterone; D000077545:Eplerenone; D043209:11-beta-Hydroxysteroid Dehydrogenase Type 2